The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct
The vaccines are currently only authorised for emergency use in the country
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
Leading brands like Sporlac, Lobun, Oxalo, Pubergen, Nano-leo and Gynogen will now be part of the JBCPL franchise
Oral semaglutide is a co-formulation of GLP-1RA semaglutide with an absorption enhancer SNAC which protects semaglutide from undergoing degradation in the stomach
ICICI Direct gives a preview on the earnings narrative for Q3FY22
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
The setting up of these 8 plants will lead to a total committed investment of Rs. 260.40 crore
MJ will be paid a one-time lumpsum licence fee of Rs 15 crore
The funds will be used to scale up existing operations and launch new products
Subscribe To Our Newsletter & Stay Updated
